Bioengineered material developed to rapidly stop bleeding in patients on blood thinners

Bioengineered material developed to rapidly stop bleeding in patients on blood thinners

More than 11 million people in the United States take anticoagulation or antiplatelet medications, such as heparin or aspirin, to treat serious conditions like heart attack and stroke. However, these medications also put patients at risk of life-threatening bleeding in the case of injury or during surgery. To improve strategies for reducing blood loss, a … Read more